TY  - GEN
AU  - Stellbrink,H-J
AU  - Lazzarin,A
AU  - Woolley,I
AU  - Llibre,J M
TI  - The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single-tablet regimen in the expanding spectrum of fixed-dose combination therapy for HIV
SN  - 1468-1293
PY  - 2021///0525
KW  - Adenine
KW  - adverse effects
KW  - Alanine
KW  - Anti-HIV Agents
KW  - CD4 Lymphocyte Count
KW  - Comorbidity
KW  - Drug Combinations
KW  - Emtricitabine
KW  - Equivalence Trials as Topic
KW  - HIV Infections
KW  - blood
KW  - Heterocyclic Compounds, 4 or More Rings
KW  - Humans
KW  - Piperazines
KW  - Pyridones
KW  - Risk Factors
KW  - Socioeconomic Factors
KW  - Tablets
KW  - Tenofovir
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1111/hiv.12833
ER  -